ReviewCancers2021

Risk of Thrombo-Embolic Events in Ovarian Cancer: Does Bevacizumab Tilt the Scale? A Systematic Review and Meta-Analysis.

Michael Saerens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.